These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 35260906)
1. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of ∆8-tetrahydrocannabinol carboxylic acid in workplace drug testing. Vikingsson S; Hart ED; Winecker RE; Cone EJ; Kuntz DJ; Clark M; Jacques M; Hayes ED; Flegel RR J Anal Toxicol; 2023 Nov; 47(8):719-725. PubMed ID: 37697897 [TBL] [Abstract][Full Text] [Related]
3. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis. Hart ED; Vikingsson S; Mitchell JM; Winecker RE; Flegel R; Hayes ED J Anal Toxicol; 2022 May; 46(5):573-576. PubMed ID: 33987675 [TBL] [Abstract][Full Text] [Related]
4. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users. Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374 [TBL] [Abstract][Full Text] [Related]
5. Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry. Poklis JL; Thompson CC; Long KA; Lichtman AH; Poklis A J Anal Toxicol; 2010 Oct; 34(8):516-20. PubMed ID: 21258613 [TBL] [Abstract][Full Text] [Related]
6. 11-Nor-9-Carboxy-Δ8-Tetrahydrocannabinol, 7-Carboxy Cannabidiol, and 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Urine by LC-MS/MS. Hughs ML; McMillin GA Methods Mol Biol; 2024; 2737():161-174. PubMed ID: 38036820 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy-∆9-THC in Hair. Hill VA; Schaffer MI; Paulsen RB; Stowe GN J Anal Toxicol; 2022 May; 46(5):487-493. PubMed ID: 34153110 [TBL] [Abstract][Full Text] [Related]
8. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays. Wolf CE; Pokhai AA; Poklis JL; Williams GR J Anal Toxicol; 2023 Nov; 47(8):732-736. PubMed ID: 37602947 [TBL] [Abstract][Full Text] [Related]
9. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis. Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266 [TBL] [Abstract][Full Text] [Related]
10. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis. Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009 [TBL] [Abstract][Full Text] [Related]
11. Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment. Franz S; Herzog J; Skopp G; Musshoff F Int J Legal Med; 2023 Jan; 137(1):79-87. PubMed ID: 36190564 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol. Coulter C; Wagner JR J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890 [TBL] [Abstract][Full Text] [Related]
13. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use. Casati S; Angeli I; Bergamaschi RF; Ravelli A; Colombo G; Binelli G; Minoli M; Orioli M Forensic Sci Int; 2022 Apr; 333():111237. PubMed ID: 35228140 [TBL] [Abstract][Full Text] [Related]
14. Determination of urinary metabolites of cannabidiol, Δ Sim YE; Kim JW; Ko BJ; Kim JY; Cheong JC; Pyo J J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123568. PubMed ID: 36527808 [TBL] [Abstract][Full Text] [Related]
15. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV. Fraser AD; Worth D Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035 [TBL] [Abstract][Full Text] [Related]
17. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry. Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869 [TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on-line solid phase extraction. Frei P; Frauchiger S; Scheurer E; Mercer-Chalmers-Bender K Drug Test Anal; 2022 Jul; 14(7):1223-1233. PubMed ID: 35187817 [TBL] [Abstract][Full Text] [Related]
19. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration. Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]